Autolus Therapeutics (Autolus Therapeutics) ROE % Adjusted to Book Value : -20.89% (As of Mar. 2024)

View and export this data going back to 2018. Start your Free Trial

What is Autolus Therapeutics ROE % Adjusted to Book Value?

Autolus Therapeutics's ROE % for the quarter that ended in Mar. 2024 was -60.78%. Autolus Therapeutics's PB Ratio for the quarter that ended in Mar. 2024 was 2.91. Autolus Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was -20.89%.

Autolus Therapeutics ROE % Adjusted to Book Value Historical Data

The historical data trend for Autolus Therapeutics's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Autolus Therapeutics ROE % Adjusted to Book Value Chart

Autolus Therapeutics Annual Data

Trend

Sep16

Sep17

Sep18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-20.83

-27.41

-35.96

-44.22

-10.10

Autolus Therapeutics Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-47.32	-40.79	-39.95	-21.02	-20.89

Competitive Comparison of Autolus Therapeutics's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Autolus Therapeutics's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Autolus Therapeutics's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Autolus Therapeutics's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Autolus Therapeutics's ROE % Adjusted to Book Value falls into.

Autolus Therapeutics ROE % Adjusted to Book Value Calculation

Autolus Therapeutics's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-101.61%	/	10.06
	=	-10.10%

Autolus Therapeutics's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	-60.78%	/	2.91
	=	-20.89%

Autolus Therapeutics ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Autolus Therapeutics's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Autolus Therapeutics (Autolus Therapeutics) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Autolus Therapeutics PLC (NAS:AUTL) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

6A3A:Germany

Address

191 Wood Lane, The MediaWorks, London, GBR, W12 7FP

Website

https://www.autolus.com

Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.